Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Arrakis Therapeutics Stock

Q: How to sell Arrakis Therapeutics stock?

If you hold private company shares of Arrakis Therapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Arrakis Therapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

arrakistx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $113.5MM

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.

Buy or sell Arrakis Therapeutics stockLearn more about Arrakis Therapeutics IPO

OverviewFinancingsValuation

Enterprise Value

Access Arrakis Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Arrakis Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Daniel Koerwer

Chief Business Officer

Heather Lounsbury

Vice President of Business & Technical Operations

Jennifer Petter Ph.D

Co-Founder & Chief Scientific Officer

Rajesh Parekh Ph.D

Co-Founder & Board Member

Michael Gilman Ph.D

Chief Executive Officer & Chairman

Alan Walts Ph.D

Co-Founder & Board Member

James Barsoum Ph.D

Senior Vice President of Biology

Henri Termeer

Co-Founder

Board Members

Carolyn Green

Matthew Cohen Ph.D

Osage Venture Partners

Rajesh Parekh Ph.D

Alan Walts Ph.D

Jakob Loven Ph.D

Nextech Invest

Nikola Trbovic Ph.D

Pfizer Ventures

Colleen Cuffaro Ph.D

Canaan Partners

Elaine Jones Ph.D

Pfizer Ventures

Peter Worland Ph.D

Celgene

Richard Gaster MD

venBio

Michael Gilman Ph.D

Timothy Shannon MD

Canaan Partners

Arrakis Therapeutics stock FAQs

Can you buy Arrakis Therapeutics stock?

As Arrakis Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Arrakis Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Arrakis Therapeutics stock?

To invest in a private company like Arrakis Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Arrakis Therapeutics stock?

Yes, you may be able to sell your Arrakis Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Arrakis Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Arrakis Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Arrakis Therapeutics a public company?

No, Arrakis Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Arrakis Therapeutics’ stock price?

Arrakis Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Arrakis Therapeutics’ private market stock price with Forge Data.

What is Arrakis Therapeutics’ stock ticker symbol?

Arrakis Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Market Screener 11/21/2019

Arrakis Therapeutics : Appoints Katrine Bosley as Chairman of the Board of Directors

Business Wire 11/19/2019

Arrakis Therapeutics Appoints Elizabeth Radcliffe as Vice President of Finance and Strategy

Arrakis Therapeutics appoints Elizabeth Radcliffe as Vice President of Finance and Strategy.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.